Contingency management (CM) is an evidence-based intervention for stimulant use and is highly effective in combination with medication for opioid use disorder. Yet, uptake of CM in opioid treatment programs that provide medication for opioid use disorder remains low. This paradox in which CM is one of the most effective interventions, yet one of the least available, represents one of the greatest research-to-practice gaps in the addiction health services field.

A recent article produced by C-DIAS leadership has been selected for the Psychiatry Services Editor’s Choice! To see the full compilation of the Editor’s Choice and to read the C-DIAS piece, visit the Psychiatry Services website today.

The C-DIAS Fellowship in Addiction Dissemination and Implementation (D&I) Science is designed for early or mid-career individuals who have a goal of using rigorous methods in D&I science to improve public access to high-quality addiction treatment. The 2023-2024 inaugural cohort consists of seven promising individuals whose research projects span a variety of topics including culturally-adapted substance use treatments, stigma-reduction, effectiveness of digital toolkits, and so much more!

This protocol paper describes a stagewise implementation-to-target (stepped “care” type) approach to implement MOUD whereby organizations engage in increasingly intensive implementation strategies as needed.

Written by members of the C-DIAS team, this paper assessed how implementation research has been used in the National Institute on Drug Abuse (NIDA) efforts to address the opioid and stimulant epidemics.

C-DIAS presented two posters at the 15th Annual Conference on the Science of Dissemination and Implementation in Health. One poster studied participant engagement in implementation trials, and the other described a micro-costing approach to estimating the total cost to implement an evidence-based practice. 

Written by members of the C-DIAS team, this paper assessed how implementation research has been used in the National Institute on Drug Abuse (NIDA) efforts to address the opioid and stimulant epidemics.

Though significant national campaigns have been launched to expand access to medications for opioid use disorder (MOUD), research has yet to properly address the challenges of implementing and sustaining MOUD in specialty addiction programs. This protocol paper describes a stagewise implementation-to-target (stepped “care” type) approach to implement MOUD whereby organizations engage in increasingly intensive implementation strategies as needed.